InvestSMART

Bioxyne Limited (ASX: BXN) - Announcements

Current share price for BXN : $0.930 0.01 (1.06%)+

ASX company news and announcements for Bioxyne Limited (BXN) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bioxyne Limited (BXN) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bioxyne Limited (BXN), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bioxyne Limited (BXN)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$214 Application for quotation of securities - BXN 11 Aug 2025 4:17PM $0.053 $0.930 risen by 1,654.72%
$214 Bioxyne Updated Investor Presentation 29 Jul 2025 8:28AM $0.049 $0.930 risen by 1,797.96%
$214 Ceasing to be a substantial holder 28 Jul 2025 7:26PM $0.049 $0.930 risen by 1,797.96%
$214 Change in substantial holding 28 Jul 2025 7:25PM $0.049 $0.930 risen by 1,797.96%
$214 Change of Shareholder Interest Notice 28 Jul 2025 7:23PM $0.049 $0.930 risen by 1,797.96%
$214 Quarterly Activities/Appendix 4C Cash Flow Report 24 Jul 2025 9:09AM $0.047 $0.930 risen by 1,878.72%
$214 Webinar 28 July 2025 5.30pm AEST 23 Jul 2025 11:09AM $0.043 $0.930 risen by 2,062.79%
$214 Director Change of Interest Notice Revised 11 Jul 2025 8:21AM $0.041 $0.930 risen by 2,168.29%
$214 Change of Director's Interest Notice 10 Jul 2025 5:58PM $0.041 $0.930 risen by 2,168.29%
$214 Investor Presentation Update 19 Jun 2025 4:57PM $0.030 $0.930 risen by 3,000%
$214 Webinar Update - Reset to 19 June 2025 18 Jun 2025 6:08PM $0.033 $0.930 risen by 2,718.18%
$214 Enters German Market Euro3.2m Manufacturing & Supply Agmt 18 Jun 2025 9:12AM $0.031 $0.930 risen by 2,900%
$214 Certificate GMP Compliance EU, UK, Singapore & Canada 18 Jun 2025 8:39AM $0.031 $0.930 risen by 2,900%
$214 Bioxyne to Host Webinar 18 June 2025 at 5PM AEST 12 Jun 2025 11:34AM $0.031 $0.930 risen by 2,900%
$214 FY25 Revenue Guidance Upgrade 12 Jun 2025 8:32AM $0.026 $0.930 risen by 3,476.92%
$214 Invitation to Investor Webinar 1 May 2025 at 4PM AEST 30 Apr 2025 1:55PM $0.022 $0.930 risen by 4,127.27%
$214 Quarterly Activities/Appendix 4C Cash Flow Report 28 Apr 2025 10:25AM $0.024 $0.930 risen by 3,775%
$214 Notification regarding unquoted securities - BXN 7 Apr 2025 8:19AM $0.026 $0.930 risen by 3,476.92%
$214 Notification regarding unquoted securities - BXN 7 Apr 2025 8:19AM $0.026 $0.930 risen by 3,476.92%
$214 Notification regarding unquoted securities - BXN 7 Apr 2025 8:19AM $0.026 $0.930 risen by 3,476.92%
$214 Prof Michael Barnes MD, FRCP Joins BXN Advisory Board 3 Apr 2025 10:42AM $0.027 $0.930 risen by 3,344.44%
$214 BXN Signs Exclusive $7m Manufacturing and Supply Agreement 3 Apr 2025 8:32AM $0.028 $0.930 risen by 3,221.43%
$214 Cleansing Notice 27 Mar 2025 11:07AM $0.029 $0.930 risen by 3,106.90%
$214 Application for quotation of securities - BXN 27 Mar 2025 11:05AM $0.029 $0.930 risen by 3,106.90%
$214 Proposed issue of securities - BXN 21 Mar 2025 10:30AM $0.029 $0.930 risen by 3,106.90%

76 - 100 of 457 results

Page 4 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.